Role of bronchiectasis in alpha1-antitrypsin deficiency patients: a comparative analysis

T. Martins Oliveira (Porto, Portugal), B. Ramos (Coimbra, Portugal), I. Sanches (Vila Nova de Gaia, Portugal), M. Guimarães (Vila Nova de Gaia, Portugal), I. Pascoal (Vila Nova de Gaia, Portugal)

Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions
Session: Chronic cough, a1-antitrypsin deficiency and other conditions
Session type: Thematic Poster
Number: 4360
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Martins Oliveira (Porto, Portugal), B. Ramos (Coimbra, Portugal), I. Sanches (Vila Nova de Gaia, Portugal), M. Guimarães (Vila Nova de Gaia, Portugal), I. Pascoal (Vila Nova de Gaia, Portugal). Role of bronchiectasis in alpha1-antitrypsin deficiency patients: a comparative analysis. 4360

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Alpha-1-antitrypsin deficiency in Kazakh subjects with COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


Genotyping and phenotyping of alpha1-antitrypsin deficiency Greek patients under augmentation therapy: a multicenter study
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


MiR-320c regulates SERPINA1 expression and is associated with pulmonary disease in alpha-1-antitrypsin deficiency
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016

Severe alpha-1-antitrypsin deficiency (A1ATD) caused by Q0Ourém mutation: A clinical characterization
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010

Efficacy of augmentation therapy for emphysema associated with alpha1-antitrypsin deficiency: enough is enough
Source: Eur Respir J 2016; 47: 35-38
Year: 2016


Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020


Use of measurements of airway resistance in the determination of reversibility in patients with emphysema associated with alpha-1-antitrypsin (A1ATD) deficiency
Source: Eur Respir J 2001; 18: Suppl. 33, 205s
Year: 2001

Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe dyspnea
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016


Enzymatic activity and clinical parameters in non-cystic fibrosis bronchiectasis: A cohort analysis
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012

Electrophoresis of blood serum: A helpful diagnostic tool for identifying respiratory patients with alpha1-antitrypsin deficiency
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015


Characterization of a population of alpha1-antitrypsin deficient (A1ATD) patients
Source: Annual Congress 2008 - COPD
Year: 2008


Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study
Source: Eur Respir J 2005; 26: Suppl. 49, 361s
Year: 2005

Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016

Does urinary peptide content differ between COPD patients with and without inherited alpha1-antitrypsin deficiency?
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017

Clinical features of alpha one antitrypsin deficiency in non cystic fibrosis bronchiectasis
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Investigation of KL-6 levels in patients with IPF- OSA overlap syndrome: Preliminary results
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Incidence of alpha-1-antitrypsin (α1-AT) deficiency in patients with COPD in Poland, preliminary report
Source: Eur Respir J 2005; 26: Suppl. 49, 440s
Year: 2005

Young adult with inherited PiMZ alpha-1-antitrypsin deficiency (A1ATD)-related bronchiectasis: characteristic of blood neutrophils and A1AT protein
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016


Validity of serum surfactant protein D as a lung-specific biomarker in monitoring asthma, chronic obstructive pulmonary disease and chronic bronchitis in Lebanese patients: Preliminary results
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012